Dabur India and Ministry of Ayush have joined hands in their fight against the growing menace of Diabetes in India with traditional Ayurveda. As part of its mission to transform the traditional knowledge of Ayurveda into a contemporary healthcare option, Dabur India has launched a revolutionary breakthrough product Dabur GLYCODAB Tablets (AYUSH 82) in partnership with C.C.R.A.S. (Ministry of Ayush, Govt. of India).
Dabur GLYCODAB Tablets will be an advanced product developed for the effective management of Diabetes. The product is backed by several clinical studies and scientific experiments that marks the marriage of traditional Ayurvedic knowledge with modern day science. A clinical study conducted with Madhumeha (Non-Insulin Dependent Diabetes Mellitus, NIDDM), demonstrated that Dabur GLYCODAB Tablets (AYUSH 82) helps reduce fasting and post-prandial blood sugar levels along with a clinical improvement in diabetic subjects after 24 weeks of treatment.
Dabur India is one of the largest FMCG Company in India. Building on a legacy of quality and experience of over 125 years, Dabur operates in key consumer products categories like Hair Care, Oral Care, Health Care, Skin Care, Home Care & Foods.
Company Name | CMP |
---|---|
Hindustan Unilever | 2259.15 |
Godrej Consumer Prod | 1208.05 |
Dabur India | 509.35 |
Colgate Palmol. (I) | 2750.00 |
Galaxy Surfactants | 2600.70 |
View more.. |